Global HER2 Targeted Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “HER2 Targeted Therapy Industry Forecast” looks at past sales and reviews total world HER2 Targeted Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected HER2 Targeted Therapy sales for 2023 through 2029. With HER2 Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER2 Targeted Therapy industry.
This Insight Report provides a comprehensive analysis of the global HER2 Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HER2 Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HER2 Targeted Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER2 Targeted Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER2 Targeted Therapy.
The global HER2 Targeted Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for HER2 Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for HER2 Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for HER2 Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key HER2 Targeted Therapy players cover GlaxoSmithKline, Bayer, Abbott, AbbVie, Pfizer, Sanofi, Agilent, Glenmark Pharmaceuticals and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of HER2 Targeted Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “HER2 Targeted Therapy Industry Forecast” looks at past sales and reviews total world HER2 Targeted Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected HER2 Targeted Therapy sales for 2023 through 2029. With HER2 Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER2 Targeted Therapy industry.
This Insight Report provides a comprehensive analysis of the global HER2 Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on HER2 Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global HER2 Targeted Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER2 Targeted Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER2 Targeted Therapy.
The global HER2 Targeted Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for HER2 Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for HER2 Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for HER2 Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key HER2 Targeted Therapy players cover GlaxoSmithKline, Bayer, Abbott, AbbVie, Pfizer, Sanofi, Agilent, Glenmark Pharmaceuticals and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of HER2 Targeted Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Monotherapy
- Combination Therapy
- Others
- Breast Cancer
- Stomach Cancer
- Head and Neck Cancer
- Lung Cancer
- Ovarian Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- Bayer
- Abbott
- AbbVie
- Pfizer
- Sanofi
- Agilent
- Glenmark Pharmaceuticals
- Merck
- Roche
- Novartis
- Astra Zeneca
- Daiichi Sankyo
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HER2 Targeted Therapy Market Size 2018-2029
2.1.2 HER2 Targeted Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 HER2 Targeted Therapy Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.2.3 Others
2.3 HER2 Targeted Therapy Market Size by Type
2.3.1 HER2 Targeted Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
2.4 HER2 Targeted Therapy Segment by Application
2.4.1 Breast Cancer
2.4.2 Stomach Cancer
2.4.3 Head and Neck Cancer
2.4.4 Lung Cancer
2.4.5 Ovarian Cancer
2.4.6 Others
2.5 HER2 Targeted Therapy Market Size by Application
2.5.1 HER2 Targeted Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
3 HER2 TARGETED THERAPY MARKET SIZE BY PLAYER
3.1 HER2 Targeted Therapy Market Size Market Share by Players
3.1.1 Global HER2 Targeted Therapy Revenue by Players (2018-2023)
3.1.2 Global HER2 Targeted Therapy Revenue Market Share by Players (2018-2023)
3.2 Global HER2 Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HER2 TARGETED THERAPY BY REGIONS
4.1 HER2 Targeted Therapy Market Size by Regions (2018-2023)
4.2 Americas HER2 Targeted Therapy Market Size Growth (2018-2023)
4.3 APAC HER2 Targeted Therapy Market Size Growth (2018-2023)
4.4 Europe HER2 Targeted Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa HER2 Targeted Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas HER2 Targeted Therapy Market Size by Country (2018-2023)
5.2 Americas HER2 Targeted Therapy Market Size by Type (2018-2023)
5.3 Americas HER2 Targeted Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 Targeted Therapy Market Size by Region (2018-2023)
6.2 APAC HER2 Targeted Therapy Market Size by Type (2018-2023)
6.3 APAC HER2 Targeted Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe HER2 Targeted Therapy by Country (2018-2023)
7.2 Europe HER2 Targeted Therapy Market Size by Type (2018-2023)
7.3 Europe HER2 Targeted Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HER2 Targeted Therapy by Region (2018-2023)
8.2 Middle East & Africa HER2 Targeted Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa HER2 Targeted Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HER2 TARGETED THERAPY MARKET FORECAST
10.1 Global HER2 Targeted Therapy Forecast by Regions (2024-2029)
10.1.1 Global HER2 Targeted Therapy Forecast by Regions (2024-2029)
10.1.2 Americas HER2 Targeted Therapy Forecast
10.1.3 APAC HER2 Targeted Therapy Forecast
10.1.4 Europe HER2 Targeted Therapy Forecast
10.1.5 Middle East & Africa HER2 Targeted Therapy Forecast
10.2 Americas HER2 Targeted Therapy Forecast by Country (2024-2029)
10.2.1 United States HER2 Targeted Therapy Market Forecast
10.2.2 Canada HER2 Targeted Therapy Market Forecast
10.2.3 Mexico HER2 Targeted Therapy Market Forecast
10.2.4 Brazil HER2 Targeted Therapy Market Forecast
10.3 APAC HER2 Targeted Therapy Forecast by Region (2024-2029)
10.3.1 China HER2 Targeted Therapy Market Forecast
10.3.2 Japan HER2 Targeted Therapy Market Forecast
10.3.3 Korea HER2 Targeted Therapy Market Forecast
10.3.4 Southeast Asia HER2 Targeted Therapy Market Forecast
10.3.5 India HER2 Targeted Therapy Market Forecast
10.3.6 Australia HER2 Targeted Therapy Market Forecast
10.4 Europe HER2 Targeted Therapy Forecast by Country (2024-2029)
10.4.1 Germany HER2 Targeted Therapy Market Forecast
10.4.2 France HER2 Targeted Therapy Market Forecast
10.4.3 UK HER2 Targeted Therapy Market Forecast
10.4.4 Italy HER2 Targeted Therapy Market Forecast
10.4.5 Russia HER2 Targeted Therapy Market Forecast
10.5 Middle East & Africa HER2 Targeted Therapy Forecast by Region (2024-2029)
10.5.1 Egypt HER2 Targeted Therapy Market Forecast
10.5.2 South Africa HER2 Targeted Therapy Market Forecast
10.5.3 Israel HER2 Targeted Therapy Market Forecast
10.5.4 Turkey HER2 Targeted Therapy Market Forecast
10.5.5 GCC Countries HER2 Targeted Therapy Market Forecast
10.6 Global HER2 Targeted Therapy Forecast by Type (2024-2029)
10.7 Global HER2 Targeted Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline HER2 Targeted Therapy Product Offered
11.1.3 GlaxoSmithKline HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer HER2 Targeted Therapy Product Offered
11.2.3 Bayer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott HER2 Targeted Therapy Product Offered
11.3.3 Abbott HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie HER2 Targeted Therapy Product Offered
11.4.3 AbbVie HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer HER2 Targeted Therapy Product Offered
11.5.3 Pfizer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi HER2 Targeted Therapy Product Offered
11.6.3 Sanofi HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Agilent
11.7.1 Agilent Company Information
11.7.2 Agilent HER2 Targeted Therapy Product Offered
11.7.3 Agilent HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Agilent Main Business Overview
11.7.5 Agilent Latest Developments
11.8 Glenmark Pharmaceuticals
11.8.1 Glenmark Pharmaceuticals Company Information
11.8.2 Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered
11.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Glenmark Pharmaceuticals Main Business Overview
11.8.5 Glenmark Pharmaceuticals Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck HER2 Targeted Therapy Product Offered
11.9.3 Merck HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche HER2 Targeted Therapy Product Offered
11.10.3 Roche HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis HER2 Targeted Therapy Product Offered
11.11.3 Novartis HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 Astra Zeneca
11.12.1 Astra Zeneca Company Information
11.12.2 Astra Zeneca HER2 Targeted Therapy Product Offered
11.12.3 Astra Zeneca HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Astra Zeneca Main Business Overview
11.12.5 Astra Zeneca Latest Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Information
11.13.2 Daiichi Sankyo HER2 Targeted Therapy Product Offered
11.13.3 Daiichi Sankyo HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Daiichi Sankyo Main Business Overview
11.13.5 Daiichi Sankyo Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global HER2 Targeted Therapy Market Size 2018-2029
2.1.2 HER2 Targeted Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 HER2 Targeted Therapy Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.2.3 Others
2.3 HER2 Targeted Therapy Market Size by Type
2.3.1 HER2 Targeted Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
2.4 HER2 Targeted Therapy Segment by Application
2.4.1 Breast Cancer
2.4.2 Stomach Cancer
2.4.3 Head and Neck Cancer
2.4.4 Lung Cancer
2.4.5 Ovarian Cancer
2.4.6 Others
2.5 HER2 Targeted Therapy Market Size by Application
2.5.1 HER2 Targeted Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
3 HER2 TARGETED THERAPY MARKET SIZE BY PLAYER
3.1 HER2 Targeted Therapy Market Size Market Share by Players
3.1.1 Global HER2 Targeted Therapy Revenue by Players (2018-2023)
3.1.2 Global HER2 Targeted Therapy Revenue Market Share by Players (2018-2023)
3.2 Global HER2 Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HER2 TARGETED THERAPY BY REGIONS
4.1 HER2 Targeted Therapy Market Size by Regions (2018-2023)
4.2 Americas HER2 Targeted Therapy Market Size Growth (2018-2023)
4.3 APAC HER2 Targeted Therapy Market Size Growth (2018-2023)
4.4 Europe HER2 Targeted Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa HER2 Targeted Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas HER2 Targeted Therapy Market Size by Country (2018-2023)
5.2 Americas HER2 Targeted Therapy Market Size by Type (2018-2023)
5.3 Americas HER2 Targeted Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC HER2 Targeted Therapy Market Size by Region (2018-2023)
6.2 APAC HER2 Targeted Therapy Market Size by Type (2018-2023)
6.3 APAC HER2 Targeted Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe HER2 Targeted Therapy by Country (2018-2023)
7.2 Europe HER2 Targeted Therapy Market Size by Type (2018-2023)
7.3 Europe HER2 Targeted Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa HER2 Targeted Therapy by Region (2018-2023)
8.2 Middle East & Africa HER2 Targeted Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa HER2 Targeted Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HER2 TARGETED THERAPY MARKET FORECAST
10.1 Global HER2 Targeted Therapy Forecast by Regions (2024-2029)
10.1.1 Global HER2 Targeted Therapy Forecast by Regions (2024-2029)
10.1.2 Americas HER2 Targeted Therapy Forecast
10.1.3 APAC HER2 Targeted Therapy Forecast
10.1.4 Europe HER2 Targeted Therapy Forecast
10.1.5 Middle East & Africa HER2 Targeted Therapy Forecast
10.2 Americas HER2 Targeted Therapy Forecast by Country (2024-2029)
10.2.1 United States HER2 Targeted Therapy Market Forecast
10.2.2 Canada HER2 Targeted Therapy Market Forecast
10.2.3 Mexico HER2 Targeted Therapy Market Forecast
10.2.4 Brazil HER2 Targeted Therapy Market Forecast
10.3 APAC HER2 Targeted Therapy Forecast by Region (2024-2029)
10.3.1 China HER2 Targeted Therapy Market Forecast
10.3.2 Japan HER2 Targeted Therapy Market Forecast
10.3.3 Korea HER2 Targeted Therapy Market Forecast
10.3.4 Southeast Asia HER2 Targeted Therapy Market Forecast
10.3.5 India HER2 Targeted Therapy Market Forecast
10.3.6 Australia HER2 Targeted Therapy Market Forecast
10.4 Europe HER2 Targeted Therapy Forecast by Country (2024-2029)
10.4.1 Germany HER2 Targeted Therapy Market Forecast
10.4.2 France HER2 Targeted Therapy Market Forecast
10.4.3 UK HER2 Targeted Therapy Market Forecast
10.4.4 Italy HER2 Targeted Therapy Market Forecast
10.4.5 Russia HER2 Targeted Therapy Market Forecast
10.5 Middle East & Africa HER2 Targeted Therapy Forecast by Region (2024-2029)
10.5.1 Egypt HER2 Targeted Therapy Market Forecast
10.5.2 South Africa HER2 Targeted Therapy Market Forecast
10.5.3 Israel HER2 Targeted Therapy Market Forecast
10.5.4 Turkey HER2 Targeted Therapy Market Forecast
10.5.5 GCC Countries HER2 Targeted Therapy Market Forecast
10.6 Global HER2 Targeted Therapy Forecast by Type (2024-2029)
10.7 Global HER2 Targeted Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline HER2 Targeted Therapy Product Offered
11.1.3 GlaxoSmithKline HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer HER2 Targeted Therapy Product Offered
11.2.3 Bayer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott HER2 Targeted Therapy Product Offered
11.3.3 Abbott HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 AbbVie
11.4.1 AbbVie Company Information
11.4.2 AbbVie HER2 Targeted Therapy Product Offered
11.4.3 AbbVie HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AbbVie Main Business Overview
11.4.5 AbbVie Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer HER2 Targeted Therapy Product Offered
11.5.3 Pfizer HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi HER2 Targeted Therapy Product Offered
11.6.3 Sanofi HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Sanofi Main Business Overview
11.6.5 Sanofi Latest Developments
11.7 Agilent
11.7.1 Agilent Company Information
11.7.2 Agilent HER2 Targeted Therapy Product Offered
11.7.3 Agilent HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Agilent Main Business Overview
11.7.5 Agilent Latest Developments
11.8 Glenmark Pharmaceuticals
11.8.1 Glenmark Pharmaceuticals Company Information
11.8.2 Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered
11.8.3 Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Glenmark Pharmaceuticals Main Business Overview
11.8.5 Glenmark Pharmaceuticals Latest Developments
11.9 Merck
11.9.1 Merck Company Information
11.9.2 Merck HER2 Targeted Therapy Product Offered
11.9.3 Merck HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Merck Main Business Overview
11.9.5 Merck Latest Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche HER2 Targeted Therapy Product Offered
11.10.3 Roche HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Roche Main Business Overview
11.10.5 Roche Latest Developments
11.11 Novartis
11.11.1 Novartis Company Information
11.11.2 Novartis HER2 Targeted Therapy Product Offered
11.11.3 Novartis HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Novartis Main Business Overview
11.11.5 Novartis Latest Developments
11.12 Astra Zeneca
11.12.1 Astra Zeneca Company Information
11.12.2 Astra Zeneca HER2 Targeted Therapy Product Offered
11.12.3 Astra Zeneca HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Astra Zeneca Main Business Overview
11.12.5 Astra Zeneca Latest Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Information
11.13.2 Daiichi Sankyo HER2 Targeted Therapy Product Offered
11.13.3 Daiichi Sankyo HER2 Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Daiichi Sankyo Main Business Overview
11.13.5 Daiichi Sankyo Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. HER2 Targeted Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Monotherapy
Table 3. Major Players of Combination Therapy
Table 4. Major Players of Others
Table 5. HER2 Targeted Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global HER2 Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 8. HER2 Targeted Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global HER2 Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 11. Global HER2 Targeted Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global HER2 Targeted Therapy Revenue Market Share by Player (2018-2023)
Table 13. HER2 Targeted Therapy Key Players Head office and Products Offered
Table 14. HER2 Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global HER2 Targeted Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global HER2 Targeted Therapy Market Size Market Share by Regions (2018-2023)
Table 19. Global HER2 Targeted Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global HER2 Targeted Therapy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas HER2 Targeted Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas HER2 Targeted Therapy Market Size Market Share by Country (2018-2023)
Table 23. Americas HER2 Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 25. Americas HER2 Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 27. APAC HER2 Targeted Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC HER2 Targeted Therapy Market Size Market Share by Region (2018-2023)
Table 29. APAC HER2 Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 31. APAC HER2 Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 33. Europe HER2 Targeted Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe HER2 Targeted Therapy Market Size Market Share by Country (2018-2023)
Table 35. Europe HER2 Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 37. Europe HER2 Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa HER2 Targeted Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa HER2 Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa HER2 Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of HER2 Targeted Therapy
Table 46. Key Market Challenges & Risks of HER2 Targeted Therapy
Table 47. Key Industry Trends of HER2 Targeted Therapy
Table 48. Global HER2 Targeted Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global HER2 Targeted Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global HER2 Targeted Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global HER2 Targeted Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. GlaxoSmithKline Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 53. GlaxoSmithKline HER2 Targeted Therapy Product Offered
Table 54. GlaxoSmithKline HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. GlaxoSmithKline Main Business
Table 56. GlaxoSmithKline Latest Developments
Table 57. Bayer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 58. Bayer HER2 Targeted Therapy Product Offered
Table 59. Bayer Main Business
Table 60. Bayer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Bayer Latest Developments
Table 62. Abbott Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 63. Abbott HER2 Targeted Therapy Product Offered
Table 64. Abbott Main Business
Table 65. Abbott HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Abbott Latest Developments
Table 67. AbbVie Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 68. AbbVie HER2 Targeted Therapy Product Offered
Table 69. AbbVie Main Business
Table 70. AbbVie HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. AbbVie Latest Developments
Table 72. Pfizer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 73. Pfizer HER2 Targeted Therapy Product Offered
Table 74. Pfizer Main Business
Table 75. Pfizer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Pfizer Latest Developments
Table 77. Sanofi Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 78. Sanofi HER2 Targeted Therapy Product Offered
Table 79. Sanofi Main Business
Table 80. Sanofi HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Sanofi Latest Developments
Table 82. Agilent Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 83. Agilent HER2 Targeted Therapy Product Offered
Table 84. Agilent Main Business
Table 85. Agilent HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Agilent Latest Developments
Table 87. Glenmark Pharmaceuticals Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 88. Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered
Table 89. Glenmark Pharmaceuticals Main Business
Table 90. Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Glenmark Pharmaceuticals Latest Developments
Table 92. Merck Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 93. Merck HER2 Targeted Therapy Product Offered
Table 94. Merck Main Business
Table 95. Merck HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Merck Latest Developments
Table 97. Roche Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 98. Roche HER2 Targeted Therapy Product Offered
Table 99. Roche Main Business
Table 100. Roche HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Roche Latest Developments
Table 102. Novartis Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 103. Novartis HER2 Targeted Therapy Product Offered
Table 104. Novartis HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Novartis Main Business
Table 106. Novartis Latest Developments
Table 107. Astra Zeneca Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 108. Astra Zeneca HER2 Targeted Therapy Product Offered
Table 109. Astra Zeneca Main Business
Table 110. Astra Zeneca HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Astra Zeneca Latest Developments
Table 112. Daiichi Sankyo Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 113. Daiichi Sankyo HER2 Targeted Therapy Product Offered
Table 114. Daiichi Sankyo Main Business
Table 115. Daiichi Sankyo HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Daiichi Sankyo Latest Developments
Table 1. HER2 Targeted Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Monotherapy
Table 3. Major Players of Combination Therapy
Table 4. Major Players of Others
Table 5. HER2 Targeted Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global HER2 Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 8. HER2 Targeted Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global HER2 Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 11. Global HER2 Targeted Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global HER2 Targeted Therapy Revenue Market Share by Player (2018-2023)
Table 13. HER2 Targeted Therapy Key Players Head office and Products Offered
Table 14. HER2 Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global HER2 Targeted Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global HER2 Targeted Therapy Market Size Market Share by Regions (2018-2023)
Table 19. Global HER2 Targeted Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global HER2 Targeted Therapy Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas HER2 Targeted Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas HER2 Targeted Therapy Market Size Market Share by Country (2018-2023)
Table 23. Americas HER2 Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 25. Americas HER2 Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 27. APAC HER2 Targeted Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC HER2 Targeted Therapy Market Size Market Share by Region (2018-2023)
Table 29. APAC HER2 Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 31. APAC HER2 Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 33. Europe HER2 Targeted Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe HER2 Targeted Therapy Market Size Market Share by Country (2018-2023)
Table 35. Europe HER2 Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 37. Europe HER2 Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa HER2 Targeted Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa HER2 Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa HER2 Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of HER2 Targeted Therapy
Table 46. Key Market Challenges & Risks of HER2 Targeted Therapy
Table 47. Key Industry Trends of HER2 Targeted Therapy
Table 48. Global HER2 Targeted Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global HER2 Targeted Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global HER2 Targeted Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global HER2 Targeted Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. GlaxoSmithKline Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 53. GlaxoSmithKline HER2 Targeted Therapy Product Offered
Table 54. GlaxoSmithKline HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. GlaxoSmithKline Main Business
Table 56. GlaxoSmithKline Latest Developments
Table 57. Bayer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 58. Bayer HER2 Targeted Therapy Product Offered
Table 59. Bayer Main Business
Table 60. Bayer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Bayer Latest Developments
Table 62. Abbott Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 63. Abbott HER2 Targeted Therapy Product Offered
Table 64. Abbott Main Business
Table 65. Abbott HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Abbott Latest Developments
Table 67. AbbVie Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 68. AbbVie HER2 Targeted Therapy Product Offered
Table 69. AbbVie Main Business
Table 70. AbbVie HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. AbbVie Latest Developments
Table 72. Pfizer Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 73. Pfizer HER2 Targeted Therapy Product Offered
Table 74. Pfizer Main Business
Table 75. Pfizer HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Pfizer Latest Developments
Table 77. Sanofi Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 78. Sanofi HER2 Targeted Therapy Product Offered
Table 79. Sanofi Main Business
Table 80. Sanofi HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Sanofi Latest Developments
Table 82. Agilent Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 83. Agilent HER2 Targeted Therapy Product Offered
Table 84. Agilent Main Business
Table 85. Agilent HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Agilent Latest Developments
Table 87. Glenmark Pharmaceuticals Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 88. Glenmark Pharmaceuticals HER2 Targeted Therapy Product Offered
Table 89. Glenmark Pharmaceuticals Main Business
Table 90. Glenmark Pharmaceuticals HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Glenmark Pharmaceuticals Latest Developments
Table 92. Merck Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 93. Merck HER2 Targeted Therapy Product Offered
Table 94. Merck Main Business
Table 95. Merck HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Merck Latest Developments
Table 97. Roche Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 98. Roche HER2 Targeted Therapy Product Offered
Table 99. Roche Main Business
Table 100. Roche HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Roche Latest Developments
Table 102. Novartis Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 103. Novartis HER2 Targeted Therapy Product Offered
Table 104. Novartis HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Novartis Main Business
Table 106. Novartis Latest Developments
Table 107. Astra Zeneca Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 108. Astra Zeneca HER2 Targeted Therapy Product Offered
Table 109. Astra Zeneca Main Business
Table 110. Astra Zeneca HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Astra Zeneca Latest Developments
Table 112. Daiichi Sankyo Details, Company Type, HER2 Targeted Therapy Area Served and Its Competitors
Table 113. Daiichi Sankyo HER2 Targeted Therapy Product Offered
Table 114. Daiichi Sankyo Main Business
Table 115. Daiichi Sankyo HER2 Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. Daiichi Sankyo Latest Developments
LIST OF FIGURES
Figure 1. HER2 Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HER2 Targeted Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. HER2 Targeted Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. HER2 Targeted Therapy Sales Market Share by Country/Region (2022)
Figure 8. HER2 Targeted Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global HER2 Targeted Therapy Market Size Market Share by Type in 2022
Figure 10. HER2 Targeted Therapy in Breast Cancer
Figure 11. Global HER2 Targeted Therapy Market: Breast Cancer (2018-2023) & ($ Millions)
Figure 12. HER2 Targeted Therapy in Stomach Cancer
Figure 13. Global HER2 Targeted Therapy Market: Stomach Cancer (2018-2023) & ($ Millions)
Figure 14. HER2 Targeted Therapy in Head and Neck Cancer
Figure 15. Global HER2 Targeted Therapy Market: Head and Neck Cancer (2018-2023) & ($ Millions)
Figure 16. HER2 Targeted Therapy in Lung Cancer
Figure 17. Global HER2 Targeted Therapy Market: Lung Cancer (2018-2023) & ($ Millions)
Figure 18. HER2 Targeted Therapy in Ovarian Cancer
Figure 19. Global HER2 Targeted Therapy Market: Ovarian Cancer (2018-2023) & ($ Millions)
Figure 20. HER2 Targeted Therapy in Others
Figure 21. Global HER2 Targeted Therapy Market: Others (2018-2023) & ($ Millions)
Figure 22. Global HER2 Targeted Therapy Market Size Market Share by Application in 2022
Figure 23. Global HER2 Targeted Therapy Revenue Market Share by Player in 2022
Figure 24. Global HER2 Targeted Therapy Market Size Market Share by Regions (2018-2023)
Figure 25. Americas HER2 Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 26. APAC HER2 Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 27. Europe HER2 Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa HER2 Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 29. Americas HER2 Targeted Therapy Value Market Share by Country in 2022
Figure 30. United States HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC HER2 Targeted Therapy Market Size Market Share by Region in 2022
Figure 35. APAC HER2 Targeted Therapy Market Size Market Share by Type in 2022
Figure 36. APAC HER2 Targeted Therapy Market Size Market Share by Application in 2022
Figure 37. China HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. India HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe HER2 Targeted Therapy Market Size Market Share by Country in 2022
Figure 44. Europe HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Figure 45. Europe HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Figure 46. Germany HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. France HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Figure 54. Egypt HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 60. APAC HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Europe HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 63. United States HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Canada HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Mexico HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Brazil HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 67. China HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Japan HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Korea HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 71. India HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Australia HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Germany HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 74. France HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 75. UK HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Italy HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Russia HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Spain HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 79. Egypt HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 80. South Africa HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 81. Israel HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 82. Turkey HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 84. Global HER2 Targeted Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global HER2 Targeted Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. HER2 Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HER2 Targeted Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. HER2 Targeted Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. HER2 Targeted Therapy Sales Market Share by Country/Region (2022)
Figure 8. HER2 Targeted Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global HER2 Targeted Therapy Market Size Market Share by Type in 2022
Figure 10. HER2 Targeted Therapy in Breast Cancer
Figure 11. Global HER2 Targeted Therapy Market: Breast Cancer (2018-2023) & ($ Millions)
Figure 12. HER2 Targeted Therapy in Stomach Cancer
Figure 13. Global HER2 Targeted Therapy Market: Stomach Cancer (2018-2023) & ($ Millions)
Figure 14. HER2 Targeted Therapy in Head and Neck Cancer
Figure 15. Global HER2 Targeted Therapy Market: Head and Neck Cancer (2018-2023) & ($ Millions)
Figure 16. HER2 Targeted Therapy in Lung Cancer
Figure 17. Global HER2 Targeted Therapy Market: Lung Cancer (2018-2023) & ($ Millions)
Figure 18. HER2 Targeted Therapy in Ovarian Cancer
Figure 19. Global HER2 Targeted Therapy Market: Ovarian Cancer (2018-2023) & ($ Millions)
Figure 20. HER2 Targeted Therapy in Others
Figure 21. Global HER2 Targeted Therapy Market: Others (2018-2023) & ($ Millions)
Figure 22. Global HER2 Targeted Therapy Market Size Market Share by Application in 2022
Figure 23. Global HER2 Targeted Therapy Revenue Market Share by Player in 2022
Figure 24. Global HER2 Targeted Therapy Market Size Market Share by Regions (2018-2023)
Figure 25. Americas HER2 Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 26. APAC HER2 Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 27. Europe HER2 Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 28. Middle East & Africa HER2 Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 29. Americas HER2 Targeted Therapy Value Market Share by Country in 2022
Figure 30. United States HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Canada HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Mexico HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Brazil HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. APAC HER2 Targeted Therapy Market Size Market Share by Region in 2022
Figure 35. APAC HER2 Targeted Therapy Market Size Market Share by Type in 2022
Figure 36. APAC HER2 Targeted Therapy Market Size Market Share by Application in 2022
Figure 37. China HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Japan HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. Korea HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Southeast Asia HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. India HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. Australia HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Europe HER2 Targeted Therapy Market Size Market Share by Country in 2022
Figure 44. Europe HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Figure 45. Europe HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Figure 46. Germany HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. France HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. UK HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Italy HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Russia HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Region (2018-2023)
Figure 52. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Type (2018-2023)
Figure 53. Middle East & Africa HER2 Targeted Therapy Market Size Market Share by Application (2018-2023)
Figure 54. Egypt HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. South Africa HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 56. Israel HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. Turkey HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 58. GCC Country HER2 Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 59. Americas HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 60. APAC HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 61. Europe HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Middle East & Africa HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 63. United States HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Canada HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 65. Mexico HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Brazil HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 67. China HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Japan HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 69. Korea HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Southeast Asia HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 71. India HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Australia HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Germany HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 74. France HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 75. UK HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Italy HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Russia HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Spain HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 79. Egypt HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 80. South Africa HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 81. Israel HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 82. Turkey HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 83. GCC Countries HER2 Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 84. Global HER2 Targeted Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 85. Global HER2 Targeted Therapy Market Size Market Share Forecast by Application (2024-2029)
